ACP Says Administration’s Move to Lower Prescription Drug Prices is a Step in the Right Direction

Statement attributable to:
Jason M. Goldman, MD, MACP
President, American College of Physicians

WASHINGTON, October 2, 2025—The American College of Physicians is encouraged by the Trump administration’s announcement on Tuesday about a pricing deal with Pfizer to help to lower the cost of prescription drugs for Medicaid enrollees and others, part of which will include a new federal website. The high cost of prescription drugs is a barrier to our patients accessing the care they need. Prescription drugs can only ever be as effective as our patients’ ability to access these treatments. Actions that lower the cost of vital treatments are crucial to ensuring the health of the American public. The administration’s focus on this issue is critical to our patients, and we urge them to ensure that the promise of Tuesday's announcement translates into savings for the American public.

*** 

About the American College of Physicians 

The American College of Physicians is the largest medical specialty organization in the United States with members in more than 172 countries worldwide. ACP membership includes 162,000 internal medicine physicians, related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on X, Facebook, Instagram, Threads and LinkedIn, and subscribe to our new RSS feed. 

Contact: Jacquelyn Blaser, (202) 261-4572, jblaser@acponline.org